HomeGSGTF • OTCMKTS
add
Gensight Biologics SA
Previous close
$0.32
Year range
$0.32 - $0.61
Market cap
34.61M EUR
Avg Volume
5.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 864.00K | -36.38% |
Operating expense | 4.57M | -53.90% |
Net income | -2.92M | 51.11% |
Net profit margin | -338.43 | 23.16% |
Earnings per share | — | — |
EBITDA | -3.67M | 55.33% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.94M | 579.73% |
Total assets | 14.99M | -10.44% |
Total liabilities | 39.82M | -9.09% |
Total equity | -24.83M | — |
Shares outstanding | 103.40M | — |
Price to book | -1.33 | — |
Return on assets | -61.75% | — |
Return on capital | 429.81% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.92M | 51.11% |
Cash from operations | -3.67M | 54.68% |
Cash from investing | 6.00K | -92.16% |
Cash from financing | 6.07M | 89.37% |
Net change in cash | 2.40M | 150.12% |
Free cash flow | -1.89M | 64.66% |
About
Founded
2012
Headquarters
Website
Employees
11
